SocialDiabetes, a digital healthstart-up and CataloniaBio & HealthTech member, has closed deals with insurance company Axa and Axenya to open up its telemedicine platform to diabetic patients in Mexico and other Latin American countries.

This platform, which also includes an app, allows healthcare professionals to monitor their patients and gives the user more control over their condition. The company uses a B2B business model and has received FDA and EMA approval after conducting several clinical trials. 

María Jesús Salido, CEO of SocialDiabetes, highlights that “the platform makes more sense than ever now with the pandemic, as diabetics are a high-risk group. So, in collaboration with CataloniaBioHT, we’ve made it available to the Spanish healthcare system free of charge.”

SocialDiabetes is preparing a bridge round prior to Series A, hoping to raise €600,000.

Read the full article in Expansión.

Photo: María Jesús Salido and Víctor Bautista, founders of SocialDiabetes - © SocialDiabetes